Diadema Partners »

Gh Research shares owned by Diadema Partners

Quarter-by-quarter ownership of Gh Research (GHRS) shares owned by Diadema Partners from 13F filings

Historical chart of Diadema Partners investment in Gh Research

Tip: Access up to 7 years of quarterly data

All positions including Gh Research held by Diadema Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gh Research by Diadema Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $377k 27k 14.06

More positions owned by Diadema Partners

United Therapeutics Corporation Put Option (UTHR)
Vertex Pharmaceuticals Incorporated (VRTX)
Viking Therapeutics (VKTX)
Capricor Therapeutics Com New Call Option (CAPR)
Abivax Sa Sponsored Ads (ABVX)
Liquidia Corporation Com New Call Option (LQDA)
Revolution Medicines (RVMD)
Apogee Therapeutics Call Option (APGE)
Bridgebio Pharma Note 1.750% 3/0
Incyte Corporation Put Option (INCY)
Kodiak Sciences Put Option (KOD)
Cytokinetics Com New Call Option (CYTK)
Johnson & Johnson (JNJ)
Cogent Biosciences (COGT)
Merck & Co Put Option (MRK)

View all positions for Diadema Partners

Top funds holding Gh Research

Lynx1 Capital Management
BVF
RA Capital Management
Rtw Investments
FMR
venBio Select Advisor
Toronto-Dominion Bank
Troluce Capital Advisors
Millennium Management
Leucadia National Corporation
5AM Venture Management
BlackRock
UBS Group
Squadron Capital Management
Foresite Capital Management VI

View all funds holding Gh Research